Chemoinformaics analysis of 2-(2-PHENYLETHYL)BENZOATE
| Molecular Weight | 225.267 | nRot | 4 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 13 |
| Exact Molecular Weight | 225.092 | nRing | 2 |
| Solubility: LogS | -3.64 | nHRing | 0 |
| Solubility: LogP | 3.781 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 35.3223 |
| nHD | 0 | BPOL | 14.7777 |
| QED | 0.869 |
| Synth | 1.466 |
| Natural Product Likeliness | -0.124 |
| NR-PPAR-gamma | 0.47 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.004 |
| HIA | 0.014 |
| CACO-2 | -4.67 |
| MDCK | 0.0000234 |
| BBB | 0.356 |
| PPB | 0.965134 |
| VDSS | 0.413 |
| FU | 0.0109938 |
| CYP1A2-inh | 0.324 |
| CYP1A2-sub | 0.145 |
| CYP2c19-inh | 0.095 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.471 |
| CYP2c9-sub | 0.077 |
| CYP2d6-inh | 0.043 |
| CYP2d6-sub | 0.11 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.158 |
| CL | 1.69 |
| T12 | 0.829 |
| hERG | 0.259 |
| Ames | 0.007 |
| ROA | 0.063 |
| SkinSen | 0.083 |
| Carcinogencity | 0.079 |
| EI | 0.98 |
| Respiratory | 0.055 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.692877 |